Search

everythinglearnresearchcommunity

for

Search:↓

Most pregnancies with SLE resulted in intrauterine growth restriction (IUGR).

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

Most women with excess male hormones have Polycystic Ovary Syndrome, and hormonal therapy can improve symptoms but may cause side effects.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The NAMS 2014 recommendations guide healthcare providers on treating health issues in midlife women, emphasizing individualized care and informed decision-making.

Some patients taking finasteride or dutasteride may have ongoing sexual problems and depression even after stopping the medication.

Menopause can lead to skin and hair problems due to hormonal changes, but hormone replacement therapy might help slow these effects.

Hair growth is influenced by dynamic changes in hair follicle cells, which could help treat hair loss.

TSH is usually the only test needed to check thyroid function in primary care.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

Vitiligo is linked to autoimmune diseases and hearing issues, so hearing tests are recommended for patients.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

Mood stabilizers like lithium and anticonvulsants have side effects that can lead to patients stopping their medication, and managing these effects is important for treatment adherence.

A new type of sudden, complete female hair loss was found, with most patients fully recovering within 6 months without needing steroid treatment.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The conclusion is that acne, alopecia, and hyperhidrosis are common skin issues with various treatments available, and accurate diagnosis is key for effective management.

Minoxidil 2% effectively treats female hair loss, promoting growth and density.

Oral contraceptives can cause skin issues like dark patches, acne, yeast infections, sensitivity to light, spider veins, skin rashes, and hair loss.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Subcutaneous contraceptives can cause side effects like menstrual changes, headaches, weight gain, and pain at the implant site.

SSRIs can cause hair loss, especially sertraline, with higher risk in women.

The review concluded that male pattern baldness is mostly seen negatively, affecting attractiveness and social appeal.

Skin problems in older people can indicate hormonal diseases, nutritional deficiencies, or conditions like diabetes, menopause, and HIV.

Proper mineral supplementation in cow-calf operations prevents health issues and economic losses.

The document concludes that quick referral and appropriate treatments are crucial for managing common skin conditions and preventing permanent damage.

In the Middle Ages, European noblewomen intentionally removed forehead hair to be fashionable, showing how beauty standards can affect the perception of hair loss.

Starving yourself can cause hair loss, but stopping the diet can improve it.

Women, younger age, and low BMI increase the risk of long COVID symptoms.

Hypothyroidism is most common in older females, with symptoms like weakness, weight gain, and hair loss.